17-BETA-HYDROXYWORTMANNIN - A POTENT INHIBITOR OF BONE-RESORPTION AND PHOSPHATIDYLINOSITOL-3-KINASE

被引:16
作者
DODGE, JA
BRYANT, HU
KIM, J
MATTER, WF
NORMAN, BH
SRINIVASAN, U
VLAHOS, CJ
SATO, M
机构
[1] Lilly Research Laboratories Eli Lilly and Company, Indianapolis
关键词
D O I
10.1016/0960-894X(95)00291-Z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-function studies on the natural product wortmannin have identified a 17 beta-hydroxy derivative as a potent inhibitor of osteoclast function in both cell and animal models. Mechanistic studies indicate osteoclast differentiation is dramatically affected by this class of compounds. Interestingly, comparable potency trends for resorption and phosphatidylinositol-3-kinase inhibition were also observed.
引用
收藏
页码:1713 / 1718
页数:6
相关论文
共 31 条
  • [21] NAKANISHI S, 1992, J BIOL CHEM, V267, P2157
  • [22] SYNTHETIC STUDIES ON THE FURAN RING OF WORTMANNIN
    NORMAN, BH
    PASCHAL, J
    VLAHOS, CJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (11) : 1183 - 1186
  • [23] CRYSTAL-STRUCTURE AND ABSOLUTE CONFIGURATION OF WORTMANNIN AND OF WORTMANNIN PARA BROMOBENZOATE
    PETCHER, TJ
    WEBER, HP
    KIS, Z
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1972, (19) : 1061 - &
  • [24] POWIS G, 1994, CANCER RES, V54, P2419
  • [25] ACTIVATION OF HUMAN NEUTROPHIL PHOSPHOLIPASE-D BY 3 SEPARABLE MECHANISMS
    REINHOLD, SL
    PRESCOTT, SM
    ZIMMERMAN, GA
    MCINTYRE, TM
    [J]. FASEB JOURNAL, 1990, 4 (02) : 208 - 214
  • [26] RIGGS BL, 1991, WESTERN J MED, V154, P63
  • [27] EFFECTS OF BISPHOSPHONATES ON ISOLATED RAT OSTEOCLASTS AS EXAMINED BY REFLECTED LIGHT-MICROSCOPY
    SATO, M
    GRASSER, W
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (01) : 31 - 40
  • [28] BISPHOSPHONATE ACTION - ALENDRONATE LOCALIZATION IN RAT BONE AND EFFECTS ON OSTEOCLAST ULTRASTRUCTURE
    SATO, M
    GRASSER, W
    ENDO, N
    AKINS, R
    SIMMONS, H
    THOMPSON, DD
    GOLUB, E
    RODAN, GA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) : 2095 - 2105
  • [29] Vlahos Chris J., 1995, Drugs of the Future, V20, P165
  • [30] WEISINGER D, 1974, EXPERIENTIA, P135